Long-Term Safety and Effectiveness of Mepolizumab 300 mg in Europe (Mepo LTF Study)

Clinical trial NCT07591753 · COMPLETED

Trial details

NCT number: NCT07591753
Sponsor: European EGPA Study Group
Status: COMPLETED
Study type: OBSERVATIONAL

Eosinophilic Granulomatosis With Polyangiitis (Churg-Strauss) (EGPA)

Start date: 2025-09-18
Primary completion: 2026-03-31
Enrollment: 591

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.